Mimi Xu

Mimi Xu

Auto-generated profile, based on publicly available information

Mimi Xu

Division of Gastrointestinal and Liver Diseases, Department of Medicine, University of Southern California, Los Angeles, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in Current Hepatology Reports
Verified
Journal Article
Open access
PDF file
MXMimi Xu
Mimi Xu
NTNorah A. Terrault
Norah A. Terrault
Purpose of Review: The World Health Assembly called to eliminate viral hepatitis as a public health threat in 2016 and proposed elimination goals by 2030. This review examined current national and global progress with hepatitis B virus elimination, and the hurdles and solutions being undertaken to achieve elimination goals. Recent Findings: Few countries are on target to achieve the elimination targets of a 95% reduction in new infections and a 65% reduction in mortality by 2030. Gaps towards elimination remain, such as low infant vaccine coverage in low-income countries and continued under-diagnosis and low rates of treatment globally. Summary: HBV elimination is feasible but will require continued focus on infant and childhood vaccine coverage, improving blood and injection safety, increasing harm reduction measures among persons who use drugs, and providing broader access to low-cost diagnostics and antiviral treatment.

11 August 2022 in Pancreatology
Verified
Journal Article
Closed access
ACAneesa R. Chowdhury
Aneesa R. Chowdhury
PCPatrick Chang
Patrick Chang
SZSelena Zhou
Selena Zhou
RDRishi Das
Rishi Das
MXMimi Xu
Mimi Xu
JBJames Buxbaum
James Buxbaum

7 June 2021
Verified
Journal Article
Closed access
SHS L Huang
S L Huang
LCL S Chen
L S Chen
MXM M Xu
M M Xu
XGX X Gong
X X Gong
BZB Zhang
B Zhang
SZS Y Zhang
S Y Zhang
Objective: To compare the efficacy, advantages and disadvantages of endoscopic CO2 laser cauterization (ECLC) and open neck surgery in the treatment of congenital pyriform sinus fistula (CPSF). Methods: From September 2014 to March 2017, 80 cases with confirmed diagnosis of CPSF received initial treatment at Guangdong Provincial People's Hospital were prospectively analyzed, including 34 males and 46 females, aged 18 to 672 (194.17±141.18) months. They were consecutively divided into endoscopic group and open-surgery group, with 40 cases in each group. Both groups of patients received surgical treatment under general anesthesia. The endoscopic group was treated by endoscopic CO2 laser cauterization, and the open-surgery group underwent the following surgery: first, we performed suspension laryngoscopy examination to confirm the presence of fistula in the bottom of the piriform fossa, then open-neck resection of congenital piriform sinus fistula with recurrent laryngeal nerve and/or lateral branch of superior laryngeal nerve anatomy plus partial thyroidectomy were performed. The data between the two groups were compared, including the operative time, intraoperative blood loss, postoperative pain, average length of stay, neck cosmetic scores, complications and cure rates. All patients were followed up in outpatient clinics. Statistical analysis was performed using SPSS 20.0 software. P<0.05 indicates that the difference is statistically significant. Results: All patients were successfully completed the operation. The operative time, intraoperative blood loss, postoperative pain and average length of hospital stay in the endoscopic group were significantly less than those in the open group [(27.4±5.5) min to (105.8±52.5) min, (0.6±0.5) ml to (33.6±41.5) ml, (1.7±0.9) points to (4.6±0.7) points, (5.9±2.9)d to(8.9±3.3)d, t values were-9.400, -5.031, -16.199, -4.293, P values were all<0.01]; The neck cosmetic score in the endoscopy group was significantly greater than that of the open group [(9.9±0.4) against (5.8±0.9) points, t=25.847, P0.05). Three months after the first treatment, the cure rate in the endoscopic group (82.5%, 33/40) was significantly lower than that in the open-neck group (100.0%, 40/40), χ²=5.64, P<0.05. The follow-up time was 12 months after the last treatment. Eighty cases were followed up and none was lost to follow-up. During the follow-up period, the cure rate of the endoscopy group (97.5%, 39/40) was compared with that of the open group (100.0%, 40/40), and the difference was not statistically significant. Conclusions: In the treatment of CPSF, the two-surgical method each has their advantages. Compared with open-neck surgery, ECLC is simpler, repeatable. ECLC has shorter time in operation and hospital stay, less complications, and less postoperative pain and more precise cosmetic results. It could be preferred for the initial treatment of CPSF and relapsed cases after cauterization. But subject to relatively low cure rate of one-time cauterization and uncertain long-term efficacy, it cannot completely replace the open-neck surgery at present.

7 February 2022 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
JKJeniffer S. Kim
Jeniffer S. Kim
OBOmar Bakr
Omar Bakr
MXMimi Xu
Mimi Xu
MHMichael Hochman
Michael Hochman
VPVeronica M. Pagán
Veronica M. Pagán

6 July 2023 in Gastroenterology
Verified
Journal Article
Closed access
CTChristine Tien
Christine Tien
MXMimi Xu
Mimi Xu
NKNiwen Kong
Niwen Kong
DLDavid Lehoang
David Lehoang
MPMichael Pimienta
Michael Pimienta
NTNorah Terrault
Norah Terrault